A DETAIL OVERVIEW ON PHYTOCHEMISTRY, PHARMACOGNOSY AND PHARMACOLOGY OF MAIDENHAIR TREE (Ginkgo biloba L).

Mayur Dattatray Suryavanshi , Sohel Mansur Shaikh , Ramnath Sominath Garje , Ms. Snehal Lad , Ms. Vaishnavi Katkar

Ginkgo biloba, Pharmacology, Memory impairment, Safety issues, Dosage forms, Anti oxidants.

The brain is the platform for our mental health. But there is a growing body of evidence, and a number of significant voices are championing the role of diet in the care and treatment of people with mental health problems. Ginkgo biloba leaf extract has shown beneficial effect in treating impairments in memory, cognitive speed, activities of daily living (ADL), edema, inflammation and free radical toxicity associated with traumatic brain injury (TBI), Alzheimer's dementia, stroke, vaso occlusive disorders, and aging. The purpose of this chapter is to provide the mechanisms of action, clinical indications, and safety of Ginkgo biloba extract (GBE). Ginkgo biloba (Gb) has demonstrated antioxidant and vasoactive properties as well as clinical benefits in several conditions such as ischemia, epilepsy, and peripheral nerve damage. Additionally, Gb is supposed to act as potential cognitive enhancer in dementia. So far, several trials have been conducted to investigate the potential effectiveness of Gb in neuropsychiatric conditions. However, the results of these studies remain controversial. We conducted a systematic review and a meta-analysis of three randomised controlled trials in patients with schizophrenia and eight randomised controlled trials in patients with dementia. Gb treatment reduced positive symptoms in patients with schizophrenia and improved cognitive function and activities of daily living in patients with dementia. No effect of Gb on negative symptoms in schizophrenic patients was found. The general lack of evidence prevents drawing conclusions regarding Gb effectiveness in other neuropsychiatric conditions (i.e., autism, depression, anxiety, attention-deficit hyperactivity disorder, and addiction). Our data support the use of Gb in patients with dementia and as an adjunctive therapy in schizophrenic patients.

Published Paper   E-Certificate

"A DETAIL OVERVIEW ON PHYTOCHEMISTRY, PHARMACOGNOSY AND PHARMACOLOGY OF MAIDENHAIR TREE (Ginkgo biloba L).", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.9, Issue 1, page no.617 - 624, January-2024, Available :https://ijsdr.org/papers/IJSDR2401088.pdf

Volume 9 Issue 1, January-2024

Pages : 617 - 624

Paper Reg. ID: IJSDR_209942

Published Paper Id: IJSDR2401088

Downloads: 000347229

Research Area: Pharmacy

Country: taluka Ashti Dist- Beed, maharashtra, India

Published Paper PDF: https://ijsdr.org/papers/IJSDR2401088

Published Paper URL: https://ijsdr.org/viewpaperforall?paper=IJSDR2401088

ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJSDR(IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition